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Fear of Phenolphthalein?
In December scientists announced that
phenolphthalein, a substance used for
almost a century in over-the-counter laxa-
tives, showed clear evidence of carcino-
genicity in rodent studies and may present
a risk to humans, particularly individuals
who ingest amounts greatly exceeding rec-
ommended doses.
The determination was made by the
National Toxicology Program, which initi-
ated toxicology and carcinogenicity studies
of phenolphthalein because no long-term
animal studies were available to allow eval-
uation of the potential risks to humans
from prolonged use of the drug. The
National Cancer Institute had nominated
phenolphthalein for study.
In the NTP studies, rats and mice were
fed phenolphthalein over a period of two
years at doses of 12,000, 25,000, and
50,000 parts per million (ppm) to rats and
3,000, 6,000, and 12,000 ppm to mice.
The rodents were then examined for the
presence of cancerous and noncancerous
pathology. The study results are summa-
rized as follows:
* dear evidence ofcarcinogenic activity in
male F344/N rats based on markedly
increased incidences ofbenign neoplasms
of the adrenal medulla and benign and
malignant neoplasms ofthe kidneys;
* some evidence ofcarcinogenic activity in
female rats based on increased incidences of
benign pheochromocytoma in the 12,000
ppm dose group, and ofbenign or malig-
nantneoplasms oftheadrenal medulla;
* dear evidence ofcarcinogenic activity in
male mice based on histiocytic sarcoma
and malignant lymphoma;
* clear evidence of carcinogenic activity in
female micebased on increased incidences
of histiocytic sarcoma, malignant lym-
phoma ofall types, lymphoma ofthymic
origin, and benign ovarian tumors.
According to the NTP, phenolph-
thalein may cause cellular alterations in
animals by a number of mechanisms
including chromosomal damage, and
through estrogenlike activity. Additional
studies are underway to further understand
the mechanisms by which phenolphthalein
acts. The NTP technical report on phe-
nolphthalein stresses, however, that it is
difficult to extrapolate human risk from
animal studies, and no population studies
of phenolphthalein users have shown an
increased risk for disease. This does not
mean, however, that the drug is necessarily
risk-free for humans. George Lucier, direc-
tor of the Environmental Toxicology
Program at the NIEHS, says, "Although
Unwanted ingredient? New research shows phenolphthalein, a drug found in many laxatives, may
have carcinogenic side effects in animals.
we can't precisely determine the relevance
of the NTP animal findings for human
risk, theydo provide a red flag ofcaution."
Alternatives in Animal Testing
The three "R's" of animal testing are
refine, reduce, and replace. Respectively,
they denote modifying toxicological test
procedures to lessen or eliminate animals'
pain, curtailing the number of animals
required for a test, and substituting test
animals with non-animal methods or phy-
logenetically lower species. Total replace-
ment would mean eliminating the use of
animals by using microbes, cells, tissues,
and other in vitro methods, as well as using
computerized information databases and
mathematical models.
Applying the three Rs to the develop-
ment and validation ofnew and improved
testing methods is mandated by Section
1301 of the National Institutes of Health
Revitalization Act of 1993 (PL 103-43).
The Interagency Coordinating Committee
on the Validation ofAlternative Methods
(ICCVAM) was established at the NIEHS
in 1994 to fulfill this mandate byestablish-
ing criteria for the validation ofalternative
testing methods, and recommending
processes by which they can be accepted
for regulatory use.
This daunting task was discussed at the
National Toxicology Program Workshop
onValidation and RegulatoryAcceptance of
Alternative Toxicological Test Methods,
held in Arlington, Virginia, 11-12
December 1995. The workshop was orga-
nizedbyICCVAM, which consists ofadhoc
representatives of 15 federal scientific and
regulatory agencies. The purpose of the
public workshop was to obtain comments
and recommendations from experts and
interested stakeholders from industry, acad-
emia, government, public interest groups,
and animal welfare organizations on a draft
reportpreparedbythe committee. Thedraft
report and workshop report was presented
at an Organization for Economic Cooper-
ation and Development (OECD) workshop
on toxicological test alternatives held in
January 1996 in Stockholm, Sweden. Neil
Wilcox, special assistant to the associate
commissioner oftheFDA, said, "The forum
successfully brought key individuals togeth-
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